Logo image of INUV

INUVO INC (INUV) Stock Fundamental Analysis

NYSEARCA:INUV - NYSE Arca - US46122W2044 - Common Stock - Currency: USD

5.88  +0.23 (+4.07%)

After market: 5.71 -0.17 (-2.89%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to INUV. INUV was compared to 282 industry peers in the Software industry. The financial health of INUV is average, but there are quite some concerns on its profitability. While showing a medium growth rate, INUV is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

INUV had negative earnings in the past year.
In the past year INUV had a positive cash flow from operations.
INUV had negative earnings in each of the past 5 years.
INUV had negative operating cash flow in 4 of the past 5 years.
INUV Yearly Net Income VS EBIT VS OCF VS FCFINUV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

INUV has a worse Return On Assets (-15.49%) than 67.38% of its industry peers.
INUV has a worse Return On Equity (-36.51%) than 63.83% of its industry peers.
Industry RankSector Rank
ROA -15.49%
ROE -36.51%
ROIC N/A
ROA(3y)-28.94%
ROA(5y)-24.97%
ROE(3y)-54.78%
ROE(5y)-43.28%
ROIC(3y)N/A
ROIC(5y)N/A
INUV Yearly ROA, ROE, ROICINUV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

INUV has a Gross Margin of 83.36%. This is amongst the best in the industry. INUV outperforms 91.84% of its industry peers.
In the last couple of years the Gross Margin of INUV has grown nicely.
INUV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 83.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.29%
GM growth 5Y6.3%
INUV Yearly Profit, Operating, Gross MarginsINUV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

4

2. Health

2.1 Basic Checks

INUV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, INUV has more shares outstanding
INUV has more shares outstanding than it did 5 years ago.
INUV has a better debt/assets ratio than last year.
INUV Yearly Shares OutstandingINUV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
INUV Yearly Total Debt VS Total AssetsINUV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

INUV has an Altman-Z score of -2.59. This is a bad value and indicates that INUV is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of INUV (-2.59) is worse than 80.50% of its industry peers.
There is no outstanding debt for INUV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.59
ROIC/WACCN/A
WACC11.33%
INUV Yearly LT Debt VS Equity VS FCFINUV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

INUV has a Current Ratio of 0.88. This is a bad value and indicates that INUV is not financially healthy enough and could expect problems in meeting its short term obligations.
INUV has a Current ratio of 0.88. This is in the lower half of the industry: INUV underperforms 78.01% of its industry peers.
INUV has a Quick Ratio of 0.88. This is a bad value and indicates that INUV is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of INUV (0.88) is worse than 77.66% of its industry peers.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.88
INUV Yearly Current Assets VS Current LiabilitesINUV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

5

3. Growth

3.1 Past

INUV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 62.50%, which is quite impressive.
Looking at the last year, INUV shows a quite strong growth in Revenue. The Revenue has grown by 18.20% in the last year.
INUV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.37% yearly.
EPS 1Y (TTM)62.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)18.2%
Revenue growth 3Y11.88%
Revenue growth 5Y6.37%
Sales Q2Q%56.89%

3.2 Future

INUV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 45.86% yearly.
The Revenue is expected to grow by 19.46% on average over the next years. This is quite good.
EPS Next Y40.51%
EPS Next 2Y45.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year27.22%
Revenue Next 2Y19.46%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
INUV Yearly Revenue VS EstimatesINUV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
INUV Yearly EPS VS EstimatesINUV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

INUV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 115.29, which means the current valuation is very expensive for INUV.
INUV's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. INUV is more expensive than 60.64% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 37.36. INUV is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 115.29
INUV Price Earnings VS Forward Price EarningsINUV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
INUV Per share dataINUV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
INUV's earnings are expected to grow with 45.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.86%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for INUV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INUVO INC

NYSEARCA:INUV (7/23/2025, 8:04:00 PM)

After market: 5.71 -0.17 (-2.89%)

5.88

+0.23 (+4.07%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-06 2025-08-06
Inst Owners18.92%
Inst Owner Change-0.32%
Ins Owners15.01%
Ins Owner Change7.27%
Market Cap84.97M
Analysts84
Price Target13.77 (134.18%)
Short Float %N/A
Short Ratio0.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)50.98%
Min EPS beat(2)1.96%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)48.53%
Min EPS beat(4)1.96%
Max EPS beat(4)100%
EPS beat(8)7
Avg EPS beat(8)30.15%
EPS beat(12)8
Avg EPS beat(12)2.78%
EPS beat(16)10
Avg EPS beat(16)-8.46%
Revenue beat(2)2
Avg Revenue beat(2)7.04%
Min Revenue beat(2)3.53%
Max Revenue beat(2)10.56%
Revenue beat(4)2
Avg Revenue beat(4)-1.18%
Min Revenue beat(4)-14.88%
Max Revenue beat(4)10.56%
Revenue beat(8)5
Avg Revenue beat(8)6.66%
Revenue beat(12)6
Avg Revenue beat(12)0.63%
Revenue beat(16)9
Avg Revenue beat(16)2.13%
PT rev (1m)815.25%
PT rev (3m)752.65%
EPS NQ rev (1m)-900%
EPS NQ rev (3m)-900%
EPS NY rev (1m)-1650.19%
EPS NY rev (3m)-1650.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.19%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.95%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 115.29
P/S 0.91
P/FCF N/A
P/OCF 69.74
P/B 6.32
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.3
EYN/A
EPS(NY)0.05
Fwd EY0.87%
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)0.08
OCFY1.43%
SpS6.47
BVpS0.93
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.49%
ROE -36.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 83.36%
FCFM N/A
ROA(3y)-28.94%
ROA(5y)-24.97%
ROE(3y)-54.78%
ROE(5y)-43.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.29%
GM growth 5Y6.3%
F-Score5
Asset Turnover2.95
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 74.92%
Cap/Sales 1.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.88
Quick Ratio 0.88
Altman-Z -2.59
F-Score5
WACC11.33%
ROIC/WACCN/A
Cap/Depr(3y)65.34%
Cap/Depr(5y)55.02%
Cap/Sales(3y)2.24%
Cap/Sales(5y)2.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y40.51%
EPS Next 2Y45.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.2%
Revenue growth 3Y11.88%
Revenue growth 5Y6.37%
Sales Q2Q%56.89%
Revenue Next Year27.22%
Revenue Next 2Y19.46%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y42.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year147.21%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y90.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y123.34%
OCF growth 3YN/A
OCF growth 5YN/A